QELBREE

viloxazine hydrochloride · Supernus Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for QELBREE, covering 2017-05-02 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD [Phase 4]